Weiqiang Zhao MD PhD, FCAP
Hematopathology, Molecular Genetics, Anatomic Pathology, Clinical Pathology
Professor of Pathology, Ohio State University College of Medicine Columbus, OH Medical Director, James Molecular Laboratory at Polaris Medical Director, Cytogenetics Lab, James Cancer Center/Hospital
Join to View Full Profile
2001 Polaris PkwyColumbus, OH 43240
Phone+1 614-366-7015
Fax+1 614-293-7013
Dr. Zhao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Weiqiang Zhao is a pathologist in Columbus, OH affiliated with multiple hospitals in the area, including Ohio State University Wexner Medical Center and James Cancer Hospital and Solove Research Institute. He received his medical degree from Hunan Medical University and has been in practice 35 years. He also speaks multiple languages, including Chinese (Mandarin). He specializes in hematopathology, molecular genetics, anatomic pathology, and clinical pathology and is experienced in the diagnosis of acute myeloid leukemia, lymphoma, non-small cell lung cancer, acute lymphoblastic leukemia, and myeloproliferative neoplasms.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Molecular Genetic Pathology, 2006 - 2007
Tulane UniversityFellowship, Hematopathology, 2005 - 2006- Tulane UniversityResidency, Pathology-Anatomic and Clinical, 2003 - 2005
Hunan Medical UniversityClass of 1982
Certifications & Licensure
OH State Medical License 2007 - 2025
LA State Medical License 2004 - 2007
American Board of Pathology Anatomic Pathology & Clinical Pathology- American Board of Pathology Pathology - Molecular Genetic
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- Analysis of Head and Neck Cancer scRNA-seq Data Identified PRDM6 Promotes Tumor Progression by Modulating Immune Gene Expression.Zhenyu Wu, Thurbu Tshering Lepcha, Dawei Zhou, Zhixian He, Guillaume N Fiches
Biorxiv. 2025-03-07 - Clinicopathologic Characteristics and Follow-Up Outcomes of Invasive Breast Carcinoma With Different Positive HER2 Fluorescence In Situ Hybridization Patterns: Experie...Zaibo Li, Yan Hu, Dan Jones, Weiqiang Zhao, Gary Tozbikian
Modern Pathology. 2025-01-01 - 13 citationsFollow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL.Jennifer A Woyach, Gabriela Perez Burbano, Amy S Ruppert, Cecelia Miller, Nyla A Heerema
Blood. 2024-04-18
Journal Articles
- Givinostat, A Type II Histone Deacetylase Inhibitor, Induces Potent Caspase-Dependent Apoptosis in Human Lymphoblastic Leukemia.Li Ying, K Zhao, C Yao, S Kahwash, Y Tang, G Zhang, K Patterson, Qi-En Wang, W Zhao, Genes & Cancer, 9/24/2016
Press Mentions
Multi-Gene Testing Could Detect More Hereditary Cancer SyndromesMay 10th, 2021
Committees
- Committee Scientific Expert, Committee to Review the Styrene Assessment in the National Toxicology Program 12th Report on Carcinogens, National Academies, Board of Environmental Studies and Toxicology, Washington DC. 2013 - 2014
Professional Memberships
- Member
- Member
- Fellow
- Fellow
Other Languages
- Chinese (Mandarin)
External Links
- Dr. Zhaohttps://pathology.osu.edu/ext/faculty/zhao.html
- OSU Molecular Laboratorieshttps://pathology.osu.edu/ext/divisions/Clinical/molpath/default.htm#faculty
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
